Lymphoblastic Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoblastic Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LL [Phase 1, Phase 2]
An ongoing Phase 1/2 pediatric trial evaluating CD7-targeted CAR-T cells for relapsed/refractory CD7-positive T-cell acute lymphoblastic leu…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating naive T cell depletion to prevent chronic graft-versus-host disease in children and young adults receiving…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies [Phase 1, Phase 2]
This clinical trial registration outlines a Phase 1/2 pediatric study of a multi-drug regimen (dasatinib, venetoclax, dexamethasone, cycloph…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies [Phase 1, Phase 2]
Ongoing Phase 1/Phase 2 clinical trial evaluating trametinib with dexamethasone and chemotherapy in children with relapsed or refractory acu…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies [Phase 1, Phase 2]
Clinical trial update for HEM-iSMART-C evaluating ruxolitinib, venetoclax, dexamethasone, cyclophosphamide, and cytarabine in pediatric pati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
An ongoing clinical trial is evaluating whether dexrazoxane hydrochloride affects biomarkers linked to cardiomyopathy and heart failure afte…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma [Phase 3]
An international Phase 3 clinical trial protocol assessing treatment for children and adolescents with lymphoblastic lymphoma; recruitment i…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT [Phase 2]
Phase 2 clinical trial evaluating inotuzumab ozogamicin with or without donor lymphocyte infusion for relapsed B-lymphoblastic leukemia or l…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children
This ClinicalTrials.gov update describes a pediatric study at University Children's Hospital Basel evaluating how glucocorticoid therapy for…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine [Phase 1]
A Phase 1 clinical trial evaluating a thiotepa, cyclophosphamide, clarithromycin, and cytarabine combination in adults with Burkitt lymphoma…
-
CLINICAL_TRIALS research · 2024-09-24Clinical Trial Update: BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma. [Phase 2]
A Phase 2 clinical trial evaluating BCL-2 inhibitors in combination with the HyperCVAD regimen for newly diagnosed T-cell lymphoblastic leuk…
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma
A clinical trial update evaluating glucose intolerance and diabetes related to steroid and PEG-asparaginase treatment in children and adoles…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Vitamin A and D Supplementation in Allogeneic HCT [Phase 2]
Phase 2 clinical trial in allogeneic hematopoietic cell transplantation is evaluating vitamin A and vitamin D supplementation, currently rec…
-
CLINICAL_TRIALS research · 2018-07-02Clinical Trial Update: Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer [NA]
Clinical trial update on caregiver-delivered massage therapy to improve quality of life in pediatric cancer patients; the study (NCT01053494…
-
CLINICAL_TRIALS research · 2018-06-21Clinical Trial Update: Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL [Phase 2, Phase 3]
Clinical trial update for chidamide-based targeted therapy in adult T-cell lymphoblastic leukemia/lymphoma (T-LBL/ALL), spanning Phase 2 and…
-
CLINICAL_TRIALS research · 2015-05-07Clinical Trial Update: Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients
A completed clinical trial update examining genetic factors linked to non-Hodgkin lymphoma in children, focusing on Burkitt lymphoma and lym…
-
CLINICAL_TRIALS research · 2014-11-13Clinical Trial Update: ATG Could Improve the Outcome Of Hematopoietic Stem Cell Transplant in Patients With Highly Aggressive T Cell Tumors
A clinical trial update evaluates anti-thymocyte globulin (ATG) in hematopoietic stem cell transplantation. The trial targets highly aggress…
-
CLINICAL_TRIALS research · 2013-10-22Clinical Trial Update: Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients
An observational study was completed evaluating cytofluorimetric analysis of cerebrospinal fluid in patients with non-Hodgkin's lymphoma.
-
CLINICAL_TRIALS research · 2013-03-19Clinical Trial Update: Hyper-CVAD Treatment in Lymphoblastic Lymphoma
This entry describes a clinical trial evaluating the Hyper-CVAD regimen for lymphoblastic lymphoma, with the study status currently listed a…
-
CLINICAL_TRIALS research · 2013-01-17Clinical Trial Update: Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma [Phase 1]
Phase 1 trial evaluating a radiolabeled monoclonal antibody with or without peripheral stem cell transplantation in children with recurrent …
-
CLINICAL_TRIALS research · 2011-01-21Clinical Trial Update: Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 clinical trial update on combination chemotherapy plus steroid therapy in children with acute lymphoblastic leukemia or lymphoblasti…